Sign in
WithdrawnNo phase

Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer

Key facts

Who runs it
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Where
Baltimore, United StatesSee the site
Trial code
Status
Withdrawn
Started
Jan 2026
Ended
19 Jan 2026
Type of study
Observational
Record updated
3 March 2026
Why it stopped
The study team decided to not move forward with enrolling patients because funding was not identified to support the project.

Who can take part

Age
18 years to 100 years
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Newly diagnosed prostate cancer within the past 12 months:
  • The patient has decided to undergo brachytherapy as treatment modality for his prostate cancer
  • Suitable volume of disease for biopsy, defined as one or more of the following:; Identifiable lesions of greater or equal to one; Clinically palpable disease corresponding to (ipsilateral to) any involved core on biopsy OR; ≥50% of biopsy cores involved with cancer
  • Patients or their legal representatives must have the ability to read, understand and provide written informed consent for the initiation of any study related procedures
  • Males 18 years of age or older
  • Signed study-specific consent form prior to registration

Who cannot take part

  • Prior history of any other malignancy which was either newly diagnosed or recurred (following prior curative treatment) within last 2 years, other than non-melanoma skin carcinoma
  • Major medical or psychiatric illness which, in the investigator's opinion, would prevent completion of treatment and would interfere with follow up

Where in United States

  • Johns Hopkins Sidney Kimmel Comprehensive Cancer CenterBaltimore, United States

About the trial

What the trial wants to find out

The primary goal of this tissue collection protocol is to establish a framework for the acquisition and banking of biospecimen collected from men undergoing brachytherapy. Biopsies of the prostate is an invasive procedure; however, in this tissue collection protocol, biopsies are acquired intraoperatively while patients are prepped for brachytherapy seed placement, thus minimizing the inconvenience of the biopsy procedure for patients. The utility of these biopsies will provide a valuable resource for molecular assessments.

The group in the trial

  • Prostate Biopsy, Urine sample and Blood sample

    For purposes of exploratory analyses, blood (whole blood, serum, plasma) and urine samples will be collected pre-IR treatment, 1-month post-implant, 6 month follow-up and 2 years follow-up. Patients will be asked to opt-in on the consent form specifically for the 2-year biopsy, otherwise they have the choice to opt out.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prostate Tissue Biopsy Collection for Men Undergoing Brachytherapy for Treatment of Localized or Locally Advanced Prostate Cancer
Record updated
3 March 2026